Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5AP | P20292 | 9/20 | 0.40 |
| ▸ | FEN1 | P39748 | 8/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP11B2 | P19099 | 5/20 | 0.38 |
| ▸ | CYP11B1 | P15538 | 4/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.35 |
| ▸ | SYK | P43405 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18842706 | 0.85 | CYP11B2 (0.40) | ALOX5APFEN1CYP11B2CYP11B1NPC1 | |
| SCHEMBL7815438 | 0.78 | ALDH1A1 (0.41) | CYP3A4CYP3A5 | |
| SCHEMBL18848895 | 0.77 | CYP1A2 (0.43) | CYP1A2RAB9A | |
| SCHEMBL14062416 | 0.77 | ALOX5AP (0.41) | ALOX5APFEN1CYP11B2CYP11B1NPC1 | |
| SCHEMBL10331375 | 0.72 | CYP1A2 (0.46) | ALOX5APCYP1A2CYP3A4CYP3A5TP53 | |
| SCHEMBL12896105 | 0.70 | CYP11B1 (0.53) | CYP1A2CYP11B2CYP11B1CYP3A4NPC1 | |
| SCHEMBL12896123 | 0.70 | MAPK8 (0.44) | FEN1CYP1A2CYP3A4 | |
| SCHEMBL26426730 | 0.70 | KDM4E (0.47) | CYP1A2CYP11B2CYP11B1RAB9A | |
| SCHEMBL7807878 | 0.69 | POLB (0.42) | CYP3A4CYP3A5 | |
| SCHEMBL15889335 | 0.68 | PIM1 (0.44) | FEN1CYP11B2CYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9776987-B2 | Amide derivatives for GPR119 agonist | CHONG KUN DANG PHARMACEUTICAL CORP (KR) | 2017-10-03 | — | — | US | disclosed |
| US-20170129875-A1 | AMIDE DERIVATIVES FOR GPR119 AGONIST | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2017-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170129875-A1 | AMIDE DERIVATIVES FOR GPR119 AGONIST | GPR119, FFAR2, GLP1R | ALOX5AP 1031/4885FEN1 4883/4885CYP1A2 1113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.